NCT01560702View on ClinicalTrials.gov

Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Blood, Injection, Injury Type PhobiaGastrointestinal Ulcer HaemorrhageAdverse Reaction to Epinephrine
Interventions
DRUG

Epinephrine

10-30 cc of 1/10000 diluted epinephrine will be injected at edges of an actively bleeding ulcer.

BIOLOGICAL

Blood

5-20 cc autologous blood immediately withdrawn from the patient will be injected at edges of the actively bleeding ulcer.

Trial Locations (1)

44519

Zagazig University Hospitals, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT01560702 - Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers | Biotech Hunter | Biotech Hunter